Overcoming the cutaneous barrier: Topical delivery platforms for targeted gene-based therapeutics in psoriasis
Journal of Controlled Release · 2026-12 · 400 · 115474
DOI: 10.1016/j.jconrel.2026.115474 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2026-12. Verfasst von Zih-Chan Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chronic Diseases and Health Promotion Research Center, Chang Gung University of Science and Technology, Puzi, Chiayi, Taiwan. Die Arbeit nennt 211 Literaturangaben. Gefördert von: Taipei Medical University.
Abstract (Originalsprache)
Psoriasis is a chronic immune-mediated skin disorder characterized by persistent inflammation, epidermal hyperproliferation, and complex interactions among immune cells, keratinocytes, cytokines, and genetic factors. Although conventional topical agents, systemic small molecules, and biologics have improved disease management, their clinical utility is often limited by insufficient efficacy, adverse effects, treatment resistance, and poor patient adherence. Recent advances in molecular biology have identified numerous pathogenic genes, signaling pathways, and regulatory RNAs involved in psoriasis, providing opportunities for the development of gene-based therapeutics, including antisense oligonucleotides, plasmid DNAs, small interfering RNAs, messenger RNAs, microRNAs, aptamers, and CRISPR/Cas9 systems. These therapeutics enable precise modulation of disease-associated targets at the genomic and transcriptional levels, offering advantages over conventional pharmacological approaches. However, their topical administration is hindered by the formidable cutaneous barrier, limited skin penetration, poor cellular uptake, and susceptibility to enzymatic degradation. This review summarizes the cellular, molecular, and genetic mechanisms underlying psoriasis pathogenesis and discusses the therapeutic potential of diverse gene-based approaches. Particular emphasis is placed on topical delivery platforms designed to overcome cutaneous barriers, including permeation enhancers, nanocarrier-based systems, and physical enhancement technologies. Recent advances in the integration of these delivery strategies with gene therapeutics for targeted psoriasis treatment are highlighted. Finally, current challenges related to delivery efficiency, long-term safety, manufacturing scalability, and regulatory approval are discussed, together with future perspectives for the clinical translation of topical gene-based therapeutics toward precision psoriasis management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chronic Diseases and Health Promotion Research Center, Chang Gung University of Science and Technology, Puzi, Chiayi, Taiwan.
- School of Pharmacy, College of Pharmacy, Taipei Medical College, Taipei, Taiwan.
- Graduate Institute of Biomedical Sciences, Chang Gung University, Kweishan, Taoyuan, Taiwan; Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan.
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia.
- Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan; Research Center for Food and Cosmetic Safety and Center for Drug Research and Development, Chang Gung U…
Förderung
- Taipei Medical University
Zitieren
APA
Lin, Z. C., Lin, C. Y., Chung, Y. K., Alalaiwe, A., & Fang, J. Y. (2026). Overcoming the cutaneous barrier: Topical delivery platforms for targeted gene-based therapeutics in psoriasis. Journal of Controlled Release, 400, 115474. https://doi.org/10.1016/j.jconrel.2026.115474
Vancouver
Lin ZC, Lin CY, Chung YK, Alalaiwe A, Fang JY. Overcoming the cutaneous barrier: Topical delivery platforms for targeted gene-based therapeutics in psoriasis. Journal of Controlled Release. 2026;400:115474. doi:10.1016/j.jconrel.2026.115474
BibTeX
@article{Lin2026,
author = {Lin, Zih-Chan and Lin, Cheng-Yu and Chung, Yu-Kuo and Alalaiwe, Ahmed and Fang, Jia-You},
title = {Overcoming the cutaneous barrier: Topical delivery platforms for targeted gene-based therapeutics in psoriasis},
journal = {Journal of Controlled Release},
year = {2026},
volume = {400},
pages = {115474},
doi = {10.1016/j.jconrel.2026.115474}
}
EUVIMED